CVS HEALTH Corp (CVS) income statement
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$85.81−2.78 (-3.14%)
Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%
CVS HEALTH Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 44.5%
- Operating margin
- 2.0%
- Net margin
- 1.2%
- Return on equity, FY2025
- 2.3%
Financial strength
- Current ratio
- 0.87
- Debt to equity
- 0.77
- Debt to assets
- 24.2%
- Cash to current liabilities
- 13.0%
Valuation
- P/E ratio
- 22.8
- Price to sales
- 0.26
- Price to book
- 1.38
- Dividend yield
- 3.10%
See a number that looks wrong?